Heartbeam (BEAT)

• Market cap: $64.8M
• 1 day: 2.10%
• 5 days: -30.17%
• 1 month: -2.02%
• 3 months: 19.70%
• 6 months: 6.11%
• Year to date: 4.29%
• 1 year: 105.93%
• 5 years: -48.19%
• 10 years: -48.19%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Employees: 20

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

7% more funds holding

Funds holding: 30 [Q2] → 32 (+2) [Q3]

1.2% more ownership

Funds ownership: 8.63% [Q2] → 9.83% (+1.2%) [Q3]

4% more capital invested

Capital invested by funds: $5.84M [Q2] → $6.05M (+$211K) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $8 229% upside
• Avg. target: $8 229% upside
• High target: $8 229% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Benchmark Bill Sutherland 68% 1-year accuracy 32 / 47 met price target

229% upside $8

Speculative Buy Reiterated

15 Nov 2024